sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Gastrointestinal OTC Drugs Market Insights and Forecast to 2026

Global Gastrointestinal OTC Drugs Market Insights and Forecast to 2026

Category : Pharmaceuticals and Healthcare QY Research Pages :112
Published Date : 2020-11-17

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Gastrointestinal OTC Drugs Market with our analysts monitoring the situation across the globe.
Gastrointestinal OTC Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal OTC Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Gastrointestinal OTC Drugs market is segmented into Laxatives Anti-Flatulents H2-Antaginists Anti-Diarrheals PPIs Anti-Emetics Other Segment by Application, the Gastrointestinal OTC Drugs market is segmented into Hospital Pharmacies Retail Pharmacies Online Pharmacies Regional and Country-level Analysis The Gastrointestinal OTC Drugs market is analysed and market size information is provided by regions (countries). The key regions covered in the Gastrointestinal OTC Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026. Competitive Landscape and Gastrointestinal OTC Drugs Market Share Analysis Gastrointestinal OTC Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gastrointestinal OTC Drugs business, the date to enter into the Gastrointestinal OTC Drugs market, Gastrointestinal OTC Drugs product introduction, recent developments, etc. The major vendors covered: GlaxoSmithKline Pfizer Johnson & Johnson Bayer Procter & Gamble Perrigo Abbott Sanofi Teva Pharmaceutical Nestle Boehringer Ingelheim Reckitt Benckiser Purdue Pharma
1 Study Coverage 1.1 Gastrointestinal OTC Drugs Product Introduction 1.2 Market Segments 1.3 Key Gastrointestinal OTC Drugs Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type 1.4.2 Laxatives 1.4.3 Anti-Flatulents 1.4.4 H2-Antaginists 1.4.5 Anti-Diarrheals 1.4.6 PPIs 1.4.7 Anti-Emetics 1.4.8 Other 1.5 Market by Application 1.5.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Gastrointestinal OTC Drugs Market Size, Estimates and Forecasts 2.1.1 Global Gastrointestinal OTC Drugs Revenue 2015-2026 2.1.2 Global Gastrointestinal OTC Drugs Sales 2015-2026 2.2 Global Gastrointestinal OTC Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.2.1 Global Gastrointestinal OTC Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Gastrointestinal OTC Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Gastrointestinal OTC Drugs Competitor Landscape by Players 3.1 Gastrointestinal OTC Drugs Sales by Manufacturers 3.1.1 Gastrointestinal OTC Drugs Sales by Manufacturers (2015-2020) 3.1.2 Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2015-2020) 3.2 Gastrointestinal OTC Drugs Revenue by Manufacturers 3.2.1 Gastrointestinal OTC Drugs Revenue by Manufacturers (2015-2020) 3.2.2 Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Gastrointestinal OTC Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Gastrointestinal OTC Drugs Revenue in 2019 3.2.5 Global Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Gastrointestinal OTC Drugs Price by Manufacturers 3.4 Gastrointestinal OTC Drugs Manufacturing Base Distribution, Product Types 3.4.1 Gastrointestinal OTC Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Gastrointestinal OTC Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Gastrointestinal OTC Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Gastrointestinal OTC Drugs Market Size by Type (2015-2020) 4.1.1 Global Gastrointestinal OTC Drugs Sales by Type (2015-2020) 4.1.2 Global Gastrointestinal OTC Drugs Revenue by Type (2015-2020) 4.1.3 Gastrointestinal OTC Drugs Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Gastrointestinal OTC Drugs Market Size Forecast by Type (2021-2026) 4.2.1 Global Gastrointestinal OTC Drugs Sales Forecast by Type (2021-2026) 4.2.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Type (2021-2026) 4.2.3 Gastrointestinal OTC Drugs Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Gastrointestinal OTC Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Gastrointestinal OTC Drugs Market Size by Application (2015-2020) 5.1.1 Global Gastrointestinal OTC Drugs Sales by Application (2015-2020) 5.1.2 Global Gastrointestinal OTC Drugs Revenue by Application (2015-2020) 5.1.3 Gastrointestinal OTC Drugs Price by Application (2015-2020) 5.2 Gastrointestinal OTC Drugs Market Size Forecast by Application (2021-2026) 5.2.1 Global Gastrointestinal OTC Drugs Sales Forecast by Application (2021-2026) 5.2.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Application (2021-2026) 5.2.3 Global Gastrointestinal OTC Drugs Price Forecast by Application (2021-2026) 6 North America 6.1 North America Gastrointestinal OTC Drugs by Country 6.1.1 North America Gastrointestinal OTC Drugs Sales by Country 6.1.2 North America Gastrointestinal OTC Drugs Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Gastrointestinal OTC Drugs Market Facts & Figures by Type 6.3 North America Gastrointestinal OTC Drugs Market Facts & Figures by Application 7 Europe 7.1 Europe Gastrointestinal OTC Drugs by Country 7.1.1 Europe Gastrointestinal OTC Drugs Sales by Country 7.1.2 Europe Gastrointestinal OTC Drugs Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Gastrointestinal OTC Drugs Market Facts & Figures by Type 7.3 Europe Gastrointestinal OTC Drugs Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Gastrointestinal OTC Drugs by Region 8.1.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Region 8.1.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Gastrointestinal OTC Drugs Market Facts & Figures by Type 8.3 Asia Pacific Gastrointestinal OTC Drugs Market Facts & Figures by Application 9 Latin America 9.1 Latin America Gastrointestinal OTC Drugs by Country 9.1.1 Latin America Gastrointestinal OTC Drugs Sales by Country 9.1.2 Latin America Gastrointestinal OTC Drugs Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Gastrointestinal OTC Drugs Market Facts & Figures by Type 9.3 Central & South America Gastrointestinal OTC Drugs Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Gastrointestinal OTC Drugs by Country 10.1.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Country 10.1.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Gastrointestinal OTC Drugs Market Facts & Figures by Type 10.3 Middle East and Africa Gastrointestinal OTC Drugs Market Facts & Figures by Application 11 Company Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Corporation Information 11.1.2 GlaxoSmithKline Description and Business Overview 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020) 11.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered 11.1.5 GlaxoSmithKline Related Developments 11.2 Pfizer 11.2.1 Pfizer Corporation Information 11.2.2 Pfizer Description and Business Overview 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Pfizer Gastrointestinal OTC Drugs Products Offered 11.2.5 Pfizer Related Developments 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Corporation Information 11.3.2 Johnson & Johnson Description and Business Overview 11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Products Offered 11.3.5 Johnson & Johnson Related Developments 11.4 Bayer 11.4.1 Bayer Corporation Information 11.4.2 Bayer Description and Business Overview 11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Bayer Gastrointestinal OTC Drugs Products Offered 11.4.5 Bayer Related Developments 11.5 Procter & Gamble 11.5.1 Procter & Gamble Corporation Information 11.5.2 Procter & Gamble Description and Business Overview 11.5.3 Procter & Gamble Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Procter & Gamble Gastrointestinal OTC Drugs Products Offered 11.5.5 Procter & Gamble Related Developments 11.6 Perrigo 11.6.1 Perrigo Corporation Information 11.6.2 Perrigo Description and Business Overview 11.6.3 Perrigo Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Perrigo Gastrointestinal OTC Drugs Products Offered 11.6.5 Perrigo Related Developments 11.7 Abbott 11.7.1 Abbott Corporation Information 11.7.2 Abbott Description and Business Overview 11.7.3 Abbott Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Abbott Gastrointestinal OTC Drugs Products Offered 11.7.5 Abbott Related Developments 11.8 Sanofi 11.8.1 Sanofi Corporation Information 11.8.2 Sanofi Description and Business Overview 11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Sanofi Gastrointestinal OTC Drugs Products Offered 11.8.5 Sanofi Related Developments 11.9 Teva Pharmaceutical 11.9.1 Teva Pharmaceutical Corporation Information 11.9.2 Teva Pharmaceutical Description and Business Overview 11.9.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 11.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Products Offered 11.9.5 Teva Pharmaceutical Related Developments 11.10 Nestle 11.10.1 Nestle Corporation Information 11.10.2 Nestle Description and Business Overview 11.10.3 Nestle Sales, Revenue and Gross Margin (2015-2020) 11.10.4 Nestle Gastrointestinal OTC Drugs Products Offered 11.10.5 Nestle Related Developments 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Corporation Information 11.1.2 GlaxoSmithKline Description and Business Overview 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020) 11.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered 11.1.5 GlaxoSmithKline Related Developments 11.12 Reckitt Benckiser 11.12.1 Reckitt Benckiser Corporation Information 11.12.2 Reckitt Benckiser Description and Business Overview 11.12.3 Reckitt Benckiser Sales, Revenue and Gross Margin (2015-2020) 11.12.4 Reckitt Benckiser Products Offered 11.12.5 Reckitt Benckiser Related Developments 11.13 Purdue Pharma 11.13.1 Purdue Pharma Corporation Information 11.13.2 Purdue Pharma Description and Business Overview 11.13.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020) 11.13.4 Purdue Pharma Products Offered 11.13.5 Purdue Pharma Related Developments 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Gastrointestinal OTC Drugs Market Estimates and Projections by Region 12.1.1 Global Gastrointestinal OTC Drugs Sales Forecast by Regions 2021-2026 12.1.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Regions 2021-2026 12.2 North America Gastrointestinal OTC Drugs Market Size Forecast (2021-2026) 12.2.1 North America: Gastrointestinal OTC Drugs Sales Forecast (2021-2026) 12.2.2 North America: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026) 12.2.3 North America: Gastrointestinal OTC Drugs Market Size Forecast by Country (2021-2026) 12.3 Europe Gastrointestinal OTC Drugs Market Size Forecast (2021-2026) 12.3.1 Europe: Gastrointestinal OTC Drugs Sales Forecast (2021-2026) 12.3.2 Europe: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026) 12.3.3 Europe: Gastrointestinal OTC Drugs Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Gastrointestinal OTC Drugs Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Gastrointestinal OTC Drugs Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Gastrointestinal OTC Drugs Market Size Forecast by Region (2021-2026) 12.5 Latin America Gastrointestinal OTC Drugs Market Size Forecast (2021-2026) 12.5.1 Latin America: Gastrointestinal OTC Drugs Sales Forecast (2021-2026) 12.5.2 Latin America: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026) 12.5.3 Latin America: Gastrointestinal OTC Drugs Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Gastrointestinal OTC Drugs Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Gastrointestinal OTC Drugs Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Gastrointestinal OTC Drugs Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Gastrointestinal OTC Drugs Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Gastrointestinal OTC Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables Table 1. Gastrointestinal OTC Drugs Market Segments Table 2. Ranking of Global Top Gastrointestinal OTC Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million) Table 4. Major Manufacturers of Laxatives Table 5. Major Manufacturers of Anti-Flatulents Table 6. Major Manufacturers of H2-Antaginists Table 7. Major Manufacturers of Anti-Diarrheals Table 8. Major Manufacturers of PPIs Table 9. Major Manufacturers of Anti-Emetics Table 10. Major Manufacturers of Other Table 11. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs) Table 12. Global Gastrointestinal OTC Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026 Table 13. Global Gastrointestinal OTC Drugs Sales by Regions 2015-2020 (K Pcs) Table 14. Global Gastrointestinal OTC Drugs Sales Market Share by Regions (2015-2020) Table 15. Global Gastrointestinal OTC Drugs Revenue by Regions 2015-2020 (US$ Million) Table 16. Global Gastrointestinal OTC Drugs Sales by Manufacturers (2015-2020) (K Pcs) Table 17. Global Gastrointestinal OTC Drugs Sales Share by Manufacturers (2015-2020) Table 18. Global Gastrointestinal OTC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 19. Global Gastrointestinal OTC Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal OTC Drugs as of 2019) Table 20. Gastrointestinal OTC Drugs Revenue by Manufacturers (2015-2020) (US$ Million) Table 21. Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2015-2020) Table 22. Key Manufacturers Gastrointestinal OTC Drugs Price (2015-2020) (USD/Pcs) Table 23. Gastrointestinal OTC Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Gastrointestinal OTC Drugs Product Type Table 25. Date of International Manufacturers Enter into Gastrointestinal OTC Drugs Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs) Table 28. Global Gastrointestinal OTC Drugs Sales Share by Type (2015-2020) Table 29. Global Gastrointestinal OTC Drugs Revenue by Type (2015-2020) (US$ Million) Table 30. Global Gastrointestinal OTC Drugs Revenue Share by Type (2015-2020) Table 31. Gastrointestinal OTC Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs) Table 32. Global Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs) Table 33. Global Gastrointestinal OTC Drugs Sales Share by Application (2015-2020) Table 34. North America Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs) Table 35. North America Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020) Table 36. North America Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million) Table 37. North America Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020) Table 38. North America Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs) Table 39. North America Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020) Table 40. North America Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs) Table 41. North America Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020) Table 42. Europe Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs) Table 43. Europe Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020) Table 44. Europe Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million) Table 45. Europe Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020) Table 46. Europe Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs) Table 47. Europe Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020) Table 48. Europe Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs) Table 49. Europe Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020) Table 50. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2015-2020) (K Pcs) Table 51. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Region (2015-2020) Table 52. Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2015-2020) (US$ Million) Table 53. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Region (2015-2020) Table 54. Asia Pacific Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs) Table 55. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020) Table 56. Asia Pacific Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs) Table 57. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020) Table 58. Latin America Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs) Table 59. Latin America Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020) Table 60. Latin Americaa Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million) Table 61. Latin America Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020) Table 62. Latin America Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs) Table 63. Latin America Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020) Table 64. Latin America Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs) Table 65. Latin America Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020) Table 66. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs) Table 67. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020) Table 68. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million) Table 69. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020) Table 70. Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs) Table 71. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020) Table 72. Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs) Table 73. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020) Table 74. GlaxoSmithKline Corporation Information Table 75. GlaxoSmithKline Description and Major Businesses Table 76. GlaxoSmithKline Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 77. GlaxoSmithKline Product Table 78. GlaxoSmithKline Recent Development Table 79. Pfizer Corporation Information Table 80. Pfizer Description and Major Businesses Table 81. Pfizer Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 82. Pfizer Product Table 83. Pfizer Recent Development Table 84. Johnson & Johnson Corporation Information Table 85. Johnson & Johnson Description and Major Businesses Table 86. Johnson & Johnson Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 87. Johnson & Johnson Product Table 88. Johnson & Johnson Recent Development Table 89. Bayer Corporation Information Table 90. Bayer Description and Major Businesses Table 91. Bayer Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 92. Bayer Product Table 93. Bayer Recent Development Table 94. Procter & Gamble Corporation Information Table 95. Procter & Gamble Description and Major Businesses Table 96. Procter & Gamble Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 97. Procter & Gamble Product Table 98. Procter & Gamble Recent Development Table 99. Perrigo Corporation Information Table 100. Perrigo Description and Major Businesses Table 101. Perrigo Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 102. Perrigo Product Table 103. Perrigo Recent Development Table 104. Abbott Corporation Information Table 105. Abbott Description and Major Businesses Table 106. Abbott Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 107. Abbott Product Table 108. Abbott Recent Development Table 109. Sanofi Corporation Information Table 110. Sanofi Description and Major Businesses Table 111. Sanofi Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 112. Sanofi Product Table 113. Sanofi Recent Development Table 114. Teva Pharmaceutical Corporation Information Table 115. Teva Pharmaceutical Description and Major Businesses Table 116. Teva Pharmaceutical Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 117. Teva Pharmaceutical Product Table 118. Teva Pharmaceutical Recent Development Table 119. Nestle Corporation Information Table 120. Nestle Description and Major Businesses Table 121. Nestle Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 122. Nestle Product Table 123. Nestle Recent Development Table 124. Boehringer Ingelheim Corporation Information Table 125. Boehringer Ingelheim Description and Major Businesses Table 126. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 127. Boehringer Ingelheim Product Table 128. Boehringer Ingelheim Recent Development Table 129. Reckitt Benckiser Corporation Information Table 130. Reckitt Benckiser Description and Major Businesses Table 131. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 132. Reckitt Benckiser Product Table 133. Reckitt Benckiser Recent Development Table 134. Purdue Pharma Corporation Information Table 135. Purdue Pharma Description and Major Businesses Table 136. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 137. Purdue Pharma Product Table 138. Purdue Pharma Recent Development Table 139. Global Gastrointestinal OTC Drugs Sales Forecast by Regions (2021-2026) (K Pcs) Table 140. Global Gastrointestinal OTC Drugs Sales Market Share Forecast by Regions (2021-2026) Table 141. Global Gastrointestinal OTC Drugs Revenue Forecast by Regions (2021-2026) (US$ Million) Table 142. Global Gastrointestinal OTC Drugs Revenue Market Share Forecast by Regions (2021-2026) Table 143. North America: Gastrointestinal OTC Drugs Sales Forecast by Country (2021-2026) (K Pcs) Table 144. North America: Gastrointestinal OTC Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 145. Europe: Gastrointestinal OTC Drugs Sales Forecast by Country (2021-2026) (K Pcs) Table 146. Europe: Gastrointestinal OTC Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 147. Asia Pacific: Gastrointestinal OTC Drugs Sales Forecast by Region (2021-2026) (K Pcs) Table 148. Asia Pacific: Gastrointestinal OTC Drugs Revenue Forecast by Region (2021-2026) (US$ Million) Table 149. Latin America: Gastrointestinal OTC Drugs Sales Forecast by Country (2021-2026) (K Pcs) Table 150. Latin America: Gastrointestinal OTC Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 151. Middle East and Africa: Gastrointestinal OTC Drugs Sales Forecast by Country (2021-2026) (K Pcs) Table 152. Middle East and Africa: Gastrointestinal OTC Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 154. Key Challenges Table 155. Market Risks Table 156. Main Points Interviewed from Key Gastrointestinal OTC Drugs Players Table 157. Gastrointestinal OTC Drugs Customers List Table 158. Gastrointestinal OTC Drugs Distributors List Table 159. Research Programs/Design for This Report Table 160. Key Data Information from Secondary Sources Table 161. Key Data Information from Primary Sources List of Figures Figure 1. Gastrointestinal OTC Drugs Product Picture Figure 2. Global Gastrointestinal OTC Drugs Sales Market Share by Type in 2020 & 2026 Figure 3. Laxatives Product Picture Figure 4. Anti-Flatulents Product Picture Figure 5. H2-Antaginists Product Picture Figure 6. Anti-Diarrheals Product Picture Figure 7. PPIs Product Picture Figure 8. Anti-Emetics Product Picture Figure 9. Other Product Picture Figure 10. Global Gastrointestinal OTC Drugs Sales Market Share by Application in 2020 & 2026 Figure 11. Hospital Pharmacies Figure 12. Retail Pharmacies Figure 13. Online Pharmacies Figure 14. Gastrointestinal OTC Drugs Report Years Considered Figure 15. Global Gastrointestinal OTC Drugs Market Size 2015-2026 (US$ Million) Figure 16. Global Gastrointestinal OTC Drugs Sales 2015-2026 (K Pcs) Figure 17. Global Gastrointestinal OTC Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 18. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2015-2020) Figure 19. Global Gastrointestinal OTC Drugs Sales Market Share by Region in 2019 Figure 20. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2015-2020) Figure 21. Global Gastrointestinal OTC Drugs Revenue Market Share by Region in 2019 Figure 22. Global Gastrointestinal OTC Drugs Sales Share by Manufacturer in 2019 Figure 23. The Top 10 and 5 Players Market Share by Gastrointestinal OTC Drugs Revenue in 2019 Figure 24. Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 25. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020) Figure 26. Global Gastrointestinal OTC Drugs Sales Market Share by Type in 2019 Figure 27. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2015-2020) Figure 28. Global Gastrointestinal OTC Drugs Revenue Market Share by Type in 2019 Figure 29. Global Gastrointestinal OTC Drugs Market Share by Price Range (2015-2020) Figure 30. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020) Figure 31. Global Gastrointestinal OTC Drugs Sales Market Share by Application in 2019 Figure 32. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2015-2020) Figure 33. Global Gastrointestinal OTC Drugs Revenue Market Share by Application in 2019 Figure 34. North America Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs) Figure 35. North America Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 36. North America Gastrointestinal OTC Drugs Sales Market Share by Country in 2019 Figure 37. North America Gastrointestinal OTC Drugs Revenue Market Share by Country in 2019 Figure 38. U.S. Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 39. U.S. Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Canada Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 41. Canada Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. North America Gastrointestinal OTC Drugs Market Share by Type in 2019 Figure 43. North America Gastrointestinal OTC Drugs Market Share by Application in 2019 Figure 44. Europe Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs) Figure 45. Europe Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 46. Europe Gastrointestinal OTC Drugs Sales Market Share by Country in 2019 Figure 47. Europe Gastrointestinal OTC Drugs Revenue Market Share by Country in 2019 Figure 48. Germany Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 49. Germany Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. France Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 51. France Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. U.K. Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 53. U.K. Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Italy Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 55. Italy Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Russia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 57. Russia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Europe Gastrointestinal OTC Drugs Market Share by Type in 2019 Figure 59. Europe Gastrointestinal OTC Drugs Market Share by Application in 2019 Figure 60. Asia Pacific Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs) Figure 61. Asia Pacific Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 62. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Region in 2019 Figure 63. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Region in 2019 Figure 64. China Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 65. China Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Japan Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 67. Japan Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. South Korea Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 69. South Korea Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. India Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 71. India Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Australia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 73. Australia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Taiwan Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 75. Taiwan Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Indonesia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 77. Indonesia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Thailand Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 79. Thailand Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Malaysia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 81. Malaysia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Philippines Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 83. Philippines Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 84. Vietnam Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 85. Vietnam Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 86. Asia Pacific Gastrointestinal OTC Drugs Market Share by Type in 2019 Figure 87. Asia Pacific Gastrointestinal OTC Drugs Market Share by Application in 2019 Figure 88. Latin America Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs) Figure 89. Latin America Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 90. Latin America Gastrointestinal OTC Drugs Sales Market Share by Country in 2019 Figure 91. Latin America Gastrointestinal OTC Drugs Revenue Market Share by Country in 2019 Figure 92. Mexico Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 93. Mexico Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 94. Brazil Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 95. Brazil Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 96. Argentina Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 97. Argentina Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 98. Latin America Gastrointestinal OTC Drugs Market Share by Type in 2019 Figure 99. Latin America Gastrointestinal OTC Drugs Market Share by Application in 2019 Figure 100. Middle East and Africa Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs) Figure 101. Middle East and Africa Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 102. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Country in 2019 Figure 103. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Country in 2019 Figure 104. Turkey Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 105. Turkey Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 106. Saudi Arabia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 107. Saudi Arabia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 108. U.A.E Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 109. U.A.E Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 110. Middle East and Africa Gastrointestinal OTC Drugs Market Share by Type in 2019 Figure 111. Middle East and Africa Gastrointestinal OTC Drugs Market Share by Application in 2019 Figure 112. North America Gastrointestinal OTC Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs) Figure 113. North America Gastrointestinal OTC Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 114. Europe Gastrointestinal OTC Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs) Figure 115. Europe Gastrointestinal OTC Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 116. Asia Pacific Gastrointestinal OTC Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs) Figure 117. Asia Pacific Gastrointestinal OTC Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 118. Latin America Gastrointestinal OTC Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs) Figure 119. Latin America Gastrointestinal OTC Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 120. Middle East and Africa Gastrointestinal OTC Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs) Figure 121. Middle East and Africa Gastrointestinal OTC Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 122. Porter's Five Forces Analysis Figure 123. Channels of Distribution Figure 124. Distributors Profiles Figure 125. Bottom-up and Top-down Approaches for This Report Figure 126. Data Triangulation Figure 127. Key Executives Interviewed

Get Free Sample

Related Reports

Global Gastrointestinal OTC Drugs Market Insights and Forecast to 2026

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Gastrointestinal OTC Drugs Market Insights and Forecast to 2026

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Gastrointestinal OTC Drugs Market Insights and Forecast to 2026

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Gastrointestinal OTC Drugs Market Insights and Forecast to 2026

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Gastrointestinal OTC Drugs Market Insights and Forecast to 2026

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)